Notably, we observed strong downregulation of BRCA1 (z = −3.5, Supplementary Data 1), indicating the potential generation of a functional ‘BRCAness’ phenotype upon SOC treatment in the BRCA1/2-wt ER+ MCF-7 breast cancer cells (Fig. 1b). This evidence concerns the gene ESR1 and breast carcinoma.